EUVIMEDEUVIMED entdecken
Editorial

Beyond Testing: Rethinking Access in Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer

Ana Carolina de Jesus Paniza iD, Fabio Ynoe Moraes iD, Gilberto Lopes iD

JCO Global Oncology · 2026-07 · 12 (7)

DOI: 10.1200/go-26-00307 ↗

Kurz gefasst

Editorial in der Zeitschrift JCO Global Oncology, 2026-07. Verfasst von Ana Carolina de Jesus Paniza und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade de Medicina do ABC-FMABC, Santo André, SP, Brasil. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Faculdade de Medicina do ABC-FMABC, Santo André, SP, Brasil.
  • Department of Oncology, Queen's University, Kingston, ON, Canada.
  • Sylvester Comprehensive Cancer Center at the University of Miami, Miami, FL.

ORCID-Profile: Ana Carolina de Jesus Paniza, Fabio Ynoe Moraes, Gilberto Lopes

Zitieren

APA

Paniza, A. C. J., Moraes, F. Y., & Lopes, G. (2026). Beyond Testing: Rethinking Access in Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer. JCO Global Oncology, 12(7). https://doi.org/10.1200/go-26-00307

Vancouver

Paniza ACJ, Moraes FY, Lopes G. Beyond Testing: Rethinking Access in Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer. JCO Global Oncology. 2026;12(7). doi:10.1200/go-26-00307

BibTeX
@article{Paniza2026,
  author = {Paniza, Ana Carolina de Jesus and Moraes, Fabio Ynoe and Lopes, Gilberto},
  title = {Beyond Testing: Rethinking Access in Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer},
  journal = {JCO Global Oncology},
  year = {2026},
  volume = {12},
  number = {7},
  doi = {10.1200/go-26-00307}
}
Kostenlos starten →